In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in ...

Robert F. Kennedy Jr.’s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA ...

Former Surgeon General Jerome Adams, who served under Trump’s first administration, criticized Kennedy’s move to cancel $500 million for mRNA projects. Adams said in a post on social media platform X ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

RFK Jr says Trump calls him 'three of four times a week' to ask why people aren't healthier yet From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.